You are here

  • Home
  • Online First
  • Petechial skin rash associated with CoronaVac vaccination: first cutaneous side effect report before phase 3 results

Article Text

Article menu

other Versions

Download PDFPDF
Letter
Petechial skin rash associated with CoronaVac vaccination: first cutaneous side effect report before phase 3 results
  1. Filiz Cebeci1,
  2. İlkay Kartal2
  1. 1Department of Dermatology, Istanbul Medeniyet University, Istanbul, Turkey
  2. 2Department of Endocrinology, Istanbul Medeniyet University, Istanbul, Turkey
  1. Correspondence to Professor Filiz Cebeci, Dermatology, Istanbul Medeniyet University, Istanbul 34720, Turkey; cebecifiliz{at}yahoo.com

https://doi.org/10.1136/ejhpharm-2021-002794

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Due to the newness of the virus, side effects of vaccines specific to SARS-CoV-2 are not yet known. CoronaVac, a purified inactivated SARS-CoV-2 vaccine developed by Sinovac Biotech (Beijing, China), has been shown to induce SARS-CoV-2-specific neutralising antibodies in mice, rats, non-human primates and in macaques.1 CoronaVac was shown to be well tolerated and did not cause dose-related safety concerns in phase 1 and 2 clinical studies involving healthy individuals aged 18–59 years2 and those aged 60 years and older.3 The most common symptom was injection site pain, and hypersensitivity reactions were the least reported side effects.2 We do not know the phase 3 efficacy and side effect results of CoronaVac, although vaccination has started. Turkey has decided on the CoronaVac within the vaccine market and is currently continuing the vaccination of elderly people following health workers. Here we share up-to-date data on an elderly person who developed post-vaccination side effects in the form of a petechial rash.

    An 82-year-old woman presented with weakness, burning in the legs and a rash. A diffuse petechial rash was observed on both lower extremities during dermatological examination (figure 1A,B). It was learned that …

    View Full Text

    Footnotes

    • Contributors FC is the primary physician of the patient discussed in this paper and supervised the process, created the idea, designed the process, reviewed the article, took part in patient care, data collection, literature review, writing and preparation of the manuscript. İK took part in the diagnosis and patient evaluation and reviewed the article.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.